At a glance
- Originator Wyeth
- Class Antihypertensives
- Mechanism of Action Angiotensin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 19 Oct 2000 Profile reviewed but no significant changes made
- 14 May 1997 No-Development-Reported for Hypertension in USA (PO)
- 31 Oct 1994 New profile